Altered platelet and coagulation function in moderate-to-severe COVID-19
Article
[키워드] absence
Altered
antibodies
Anticoagulant
bleeding
Blood
blood clot
C-reactive protein
clot
Coagulation
coagulation function
Coagulopathy
Combination
Comorbidities
consumption coagulopathy
contraction
correlated
Course
COVID-19
decrease
disease severity
Disseminated intravascular coagulation
distribution
dysfunction
erythrocyte
examined
Hemostasis
hemostatic disorder
hypercoagulability
immunosuppressive drugs
in vitro
Infection
Local
manifested
moderate
moderate-to-severe COVID-19
mortality risk
Obstructive
parameters
Patient
patients
patients with moderate
Platelet
polyhedral
porous
Prognostic markers
Prophylaxis
prothrombotic
receiving
severe COVID-19
systemic inflammation
thrombotic complication
[DOI] 10.1038/s41598-021-95397-6 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41598-021-95397-6 PMC 바로가기 [Article Type] Article